Rite Aid (RAD) Tops Q2 EPS by 2c; Comps Flat; Issues FY12 Revs Outlook
Tweet Send to a FriendGet Alerts RAD Hot Sheet
Price: $3.11 --0%
EPS Growth %: +228.6%
Financial Fact:
Cumulative preferred stock dividends: -2.69M
Today's EPS Names:
IHS, MEI, PIR, More
EPS Growth %: +228.6%
Financial Fact:
Cumulative preferred stock dividends: -2.69M
Today's EPS Names:
IHS, MEI, PIR, More
Trade RAD Now!
Rite Aid (NYSE: RAD) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.2 billion.
Same store sales for the quarter were flat over the prior year 13-week period, consisting of a 1.4 percent increase in front end sales offset by a 0.7 percent decrease in pharmacy sales.
Rite Aid sees FY2012 revenue of $25.1-25.4 billion, versus the consensus of $25.4 billion.
For earnings history and earnings-related data on Rite Aid (RAD) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Same store sales for the quarter were flat over the prior year 13-week period, consisting of a 1.4 percent increase in front end sales offset by a 0.7 percent decrease in pharmacy sales.
Rite Aid sees FY2012 revenue of $25.1-25.4 billion, versus the consensus of $25.4 billion.
For earnings history and earnings-related data on Rite Aid (RAD) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Rite Aid (RAD) Reports In-Line Q1 EPS; Guides FY14 EPS Below Views
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- Pier 1 Imports, Inc. (PIR) Reports In-Line Q1 EPS; Guides FY14 EPS
Create E-mail Alert Related Categories
Earnings, Guidance, Retail SalesRelated Entities
EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

